Berkshire Hathaway 10-Qquarter ended 2026-09-30

Executive Summary

Berkshire Hathaway earns premiums from insurance customers and sells freight transportation, energy, manufactured goods and retail services to businesses and consumers. It expanded chemicals and homebuilding through acquisitions while continuing to invest in its railroad and utilities and retaining substantial liquidity. Q3 revenue grew 11%, but operating-business pretax earnings fell 5.2% as weaker insurance results outweighed improvements elsewhere. Net earnings fell 28%, principally because investment gains were smaller; the investor question is whether growth outside insurance can offset deteriorating underwriting profitability.

What's Happening in the Business

Insurance was the main operating setback. GEICO faced higher claim frequency and severity, lower average earned premiums per policy, and increased commissions and advertising. Underwriting earnings weakened despite no significant catastrophe losses during the first nine months. Insurance still provided inexpensive investment funding: float—premiums held before claims are paid—reached ≈$179B, and underwriting remained profitable, making its average cost negative.

Acquisitions broadened manufacturing. Berkshire bought OxyChem for $9.4B on 1/2/2026 and Taylor Morrison Home Corporation for ≈$6.8B on 7/24/2026. OxyChem’s legacy environmental liabilities stayed with Occidental. These purchases expanded chemicals and homebuilding, but building-products earnings weakened despite higher sales, showing that acquired revenue did not translate uniformly into profit growth.

BNSF benefited from higher freight volumes and revenue per shipment, while utilities gained from electricity demand and approved rates. Both require continuing investment: together they accounted for $10.2B of capital expenditures through September, with management forecasting ≈$4.7B more during 2026.

Key Financial Highlights

• Insurance: Q3 pretax underwriting earnings fell 47% to $1.68B; investment income fell 11% to $3.32B. GEICO’s 9M underwriting earnings fell 41% to $3.39B as its loss ratio increased 4.9 percentage points to 75.7%.
• Manufacturing: Industrial-products revenue rose 29% to $12.2B in Q3. OxyChem contributed $1.3B of revenue and $71M of pretax earnings; Taylor Morrison added ≈$1.1B of home sales. Acquisition-accounting depreciation and amortization weighed on OxyChem’s contribution.
• Transportation and distribution: BNSF’s 9M freight volume rose 4.2%, while revenue per shipment rose 7.1%, partly from fuel surcharges. Pilot’s growth primarily reflected higher fuel prices, not equivalent underlying volume growth; McLane faced weaker gross margins and lower inventory price-change gains.
• Investment gains: Q3 pretax gains fell 46% to $11.9B because equity-security fair-value movements were less favorable. Equity-method earnings improved to $1.40B from a $(4.29)B loss, partly cushioning that decline.
• Capital allocation: Capital expenditures rose 9.6% to $16.1B, leaving $17.8B after capital spending. Cash acquisition spending was $16.2B, and cash spent repurchasing shares was $13.8B vs none a year earlier; conversion-adjusted equivalent shares outstanding fell 1.3%. Insurance and other businesses held $352B of cash and Treasury bills, net of unsettled purchase payables.

Risk Assessment

• Wildfire litigation: PacifiCorp’s ≈$566M unpaid accrual may not cover ultimate losses; further material losses are possible, no additional insurance recoveries are expected, and the James litigation remains under review.
• Insurance pricing and reserves: GEICO’s worsening claims economics, alongside favorable prior-year reserve adjustments supporting other insurers, creates exposure if premiums or reserves prove inadequate.
• Investment concentration: Five holdings represent 65% of the $336B equity portfolio, making reported earnings and investment value sensitive to a small group of companies.
• Brokerage litigation: HomeServices faces Texas claims asserting ≈$9B in damages, separate from its nationwide settlement, creating potentially significant additional exposure.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: FY2025 10-K.

What to Watch

• GEICO recovery: Its loss ratio is 75.7% for 9M. Stabilizing claims costs and premiums would support underwriting recovery; further deterioration would deepen the insurance earnings drag.
• Manufacturing integration: OxyChem and Taylor Morrison are contributing sales. Subsequent filings should show whether earnings grow alongside acquired revenue or chemicals and housing weakness constrain returns.
• Railroad and utility investment: Freight volumes and utility demand are growing. Sustained earnings gains would validate capital spending; fuel, maintenance and wildfire-prevention costs outrunning pricing would weaken that case.
• Capital deployment: Repurchases resumed alongside acquisitions, while liquidity stayed substantial. Watch whether equivalent shares continue shrinking and acquired businesses add earnings without materially reducing financial flexibility.